معرفی
Vincent Sauzeau serves as a Research Director (DR2 Inserm) at the University of Nantes' Institute of Thorax, co-leading Team III focused on Vascular and Lung Diseases within UMR_S 1087/UMR_C 6291 research unit. His work bridges Inserm and university infrastructure at the IRT-UN facility in Nantes.
Research expertise centers on Rho protein signaling pathways in vascular and airways smooth muscle cells, with investigations spanning physiological mechanisms to pathophysiological applications. His laboratory identifies novel therapeutic targets for cardiovascular and pulmonary disorders through intracellular signaling analysis, attracting sustained national grant funding and technology transfer partnerships with Ouest Valorisation.
Scientific recognition includes:
- Young Investigator Award during Spanish postdoctoral training
- Spanish Biomedical Research Award
- AstraZeneca Target Innovation Program (2015)
- Sanofi Innovation Award Europe (2020)
Funding derives from competitive national grants and industry collaborations, supporting the development of six patented technologies. His research group operates within the Institute of Thorax's specialized infrastructure for cardiovascular and respiratory disease modeling, maintaining active partnerships with pharmaceutical innovators.
